The Latest Cardiac and Vascular News
NEWTOWN, Pa., March 7, 2019 /PRNewswire/ — Micro Interventional Devices, Inc. (MID) Chairman, President and CEO, Michael Whitman, and OSCOR, Inc. President and CEO, Thomas Osypka, are pleased to announce a strategic alliance that leverages each company’s unique strengths and capabilities to further develop and commercialize innovative solutions to structural heart disease, specifically, MID’s MIA™, Minimally […]
SAN DIEGO, March 05, 2019 (GLOBE NEWSWIRE) — REVA Medical, Inc. (ASX: RVA) (“REVA” or the “Company”) said today that on 6 March 2019 (AEDT), the Australian Securities Exchange issued a market announcement indicating that the securities of the Company will remain suspended from quotation at the Company’s request until […]
Santa Monica, CA, March 06, 2019 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the electrophysiology (EP) marketplace, today announced that the Company appointed Dr. Barry Keenan, Ph.D, MBA, PMP to head up BioSig’s […]
MEMPHIS, Tenn., March 5, 2019 /PRNewswire/ — Le Bonheur Children’s Hospital will expand its Heart Institute with a two-story, $37.6 million addition. This expansion will add 19 additional beds to the Heart Institute to create a 31-bed dedicated Cardiovascular Unit. The hospital will expand west to the corner of Poplar Avenue and Dunlap Street. “We […]
ATLANTA, March 5, 2019 /PRNewswire/ — CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the upcoming Cowen and Company 39th Annual Health Care Conference on Monday, March 11, 2019 at The Boston Marriott Copley Place in Boston. A live webcast of the Company’s presentation is […]
IRVINE, Calif.–(BUSINESS WIRE)–Endologix, Inc. (the “Company”) (NASDAQ: ELGX) previously announced that a proposal was approved at its Special Meeting of Stockholders, held February 22, 2019, authorizing its Board of Directors to amend the Company’s certificate of incorporation to effect a reverse stock split of the Company’s issued and outstanding shares […]
WALTHAM, Mass.–(BUSINESS WIRE)–Corindus Vascular Robotics, Inc. (NYSE American: CVRS), a leading developer of precision vascular robotics, announced today that Mark Toland, President and Chief Executive Officer, will present at the 39thAnnual Cowen Health Care Conference as follows: Date: Wednesday, March 13, 2019 Time: 10:40 a.m. Eastern Daylight Time Location: Boston […]
ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced that management will present and host investor meetings at the following three conferences: Cowen 39th Annual Health Care Conference Monday, March […]
WASHINGTON, March 5, 2019 /PRNewswire/ — MCRA, LLC, a leading medical device consulting firm and clinical research organization (CRO) that integrates regulatory, clinical research, reimbursement, compliance and quality assurance, is pleased to announce the expansion of its cardiovascular consulting activities through the hiring of Michael C. John, MPH, as its new Vice President […]
DUBLIN – March 4, 2019 – Medtronic plc (the “Company”) (NYSE:MDT) today announced the upsizing of the previously-announced cash tender offers by its wholly-owned subsidiaries, Medtronic, Inc. and Covidien International Finance S.A. (“CIFSA” and, together with Medtronic, Inc., the “Offerors”) for up to $1.9 billion combined aggregate purchase price (excluding accrued […]
